Trial Profile
A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 14 May 2016 New trial record